Skip to main content
    M

    Medtronic PLC (MDT)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $102.90
    +0.04 (+0.04%)

    Market Cap: $131.57B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Medtronic PLC (MDT) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Medtronic (MDT) trades at 18.0x trailing earnings and 3.5x sales. Its P/E of 18.0x is above its 5-year median of 16.2x. Its forward P/E is 17.2x. The median P/E across 11 similar companies is 21.8x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 4.7% higher over the next year. Its free cash flow yield is 4.7%.

    MultipleValue
    P/E (trailing)18.0x
    Forward P/E17.2x
    Price to sales3.5x
    Price to book2.6x
    EV/EBITDA15.4x
    Price to FCF21.5x
    EV/FCF25.8x
    PEG1.9
    FCF yield4.7%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 4.0% above 17.3x, its P/S is 7.9% below 3.8x and its P/B is 8.3% above 2.4x.

    MultipleCurrent5-year median10-year median
    P/E18.0x16.2x17.3x
    P/S3.5x3.5x3.8x
    P/B2.6x2.3x2.4x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 14.6x in 2022 to 32.0x in 2020.

    Year endPriceP/EP/SP/B
    2025$96.0617.1x3.5x2.5x
    2024$79.8815.2x3.2x2.1x
    2023$82.3815.5x3.4x2.1x
    2022$77.7214.6x3.4x2.0x
    2021$103.4518.7x4.4x2.7x
    2020$117.1432.0x5.6x3.1x
    2019$113.4521.0x4.9x3.0x
    2018$90.9618.3x4.1x2.5x
    2017$80.7517.4x3.7x2.1x
    2016$71.2315.9x3.4x2.0x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About MDT

    What is MDT's forward P/E ratio?

    Medtronic has a forward P/E ratio of 17.2x.

    Is MDT stock overvalued?

    GNG's valuation label for MDT is Fairly valued. Its P/E of 18.0x compares with a median of 21.8x across 11 similar companies.

    What is MDT's price to sales ratio?

    Medtronic has a price to sales ratio of 3.5x.

    What is Medtronic's average P/E ratio over 5 years?

    Medtronic's median P/E over the last 5 years is 16.2x, from 60 month-end values through Oct 2026.

    What is MDT's PEG ratio?

    Medtronic has a PEG ratio of 1.9.